We are a company with the talent and experience to deliver unique marketing-focused solutions, powered by technology and informed by a deep, proven operational track record.
Advertising can be the beginning of a beautiful relationship. All it takes is recognizing the value of a person`s time for what it is, honestly and directly, and making sure the time you spend together is enjoyable—just like any other relationship in life. Consumers are more valuable to brands who treat them like partners. Dabbl exists to make this possible, at scale.
Eli Global was established by a young entrepreneur almost three decades ago—with no financial backing and a lot of naysayers. He believed that he could take on and beat the market leaders in his industry. Armed with his self-drive, passion, determination and entrepreneurial spirit, he persevered after years of 100+ hour work weeks, numerous failures, worrying about month-end payroll, and even sleeping under his desk at times. He grew his business organically to be the national leader in his industry and then set out to grow even more. The secret to his success? Finding like-minded people who experienced similar hardships and successes. Over the past 25 years Eli Global has grown to partner with over 80 such entrepreneurs, welcoming their businesses to our ever-growing group of entrepreneurial, independent businesses. And this is just the beginning.
Founded by four leading media organizations, Nucleus Marketing Solutions is a true national content marketing network for integrated multimedia solutions, offering advertisers a brand safe, easy to access and scalable distribution alternative. Providing innovative solutions for national advertisers across a group of premier premium publishers in news media, Nucleus offer brands trusted and influential advertising environments, and access to 70% of consumers in the top 30 U.S. markets across existing and emerging digital platforms.
From seed-stage to sales, we deliver comprehensive, strategic communications support across the breadth of biotech.